Package Leaflet: Information for the Patient
Claritromicina Accord 500 mg Film-Coated Tablets EFG
Clarithromycin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Claritromicina Accord contains the active substance clarithromycin, which belongs to a group of medicines called macrolide antibiotics. Antibiotics stop the growth of certain bacteria that cause infections. Claritromicina Accord is used to treat bacterial infections, which must first be diagnosed by your doctor, such as:
Claritromicina Accord is indicated in adults and adolescents 12 years of age and older.
Do not take Claritromicina Accord:
Warnings and precautions
Consult your doctor or pharmacist before taking Claritromicina Accord:
Children under 12 years
Claritromicina Accord is not suitable for use in children under 12 years of age.
Other medicines and Claritromicina Accord
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not take Claritromicina Accord if you are taking:
You should pay special attention if you are taking:
Clarithromycin does not interact with oral contraceptives.
Taking Claritromicina Accord with food and drink
Claritromicina Accord can be taken with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Driving and using machines
Claritromicina Accord may make you feel drowsy, dizzy, or confused. Do not drive or operate machinery if you are affected.
Claritromicina Accord contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free"
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
The recommended doses are:
Adults and adolescents (12 years of age and older):
500 mg twice a day in combination with other medicines for the treatment of Helicobacter pylori.
Your doctor will decide the best combination of treatment for you. If you are not sure what medicine to take or when to take it, talk to your doctor.
Use in children and adolescents
Claritromicina Accord is not recommended for use in children under 12 years of age. For these patients, other pharmaceutical forms are available, such as suspensions.
Liver or kidney problems
If you have liver or severe kidney problems, your doctor may need to reduce your dose. Clarithromycin should not be taken for more than 14 days if you have these problems.
Method of administration
Claritromicina Accord should be swallowed preferably with a glass of water.
If you take more Claritromicina Accord than you should
If you accidentally take more tablets in one day than your doctor has told you, or if a child accidentally swallows some tablets, contact your doctor or the nearest hospital emergency department immediately. An overdose is likely to cause vomiting and stomach pain. Please take this leaflet, the remaining tablets, and the packaging to the hospital or doctor so they know what tablets were taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Claritromicina Accord
If you forget to take a dose of Claritromicina Accord, take it as soon as you remember. If it is almost time for your next dose, do not take the missed dose and continue with the rest as before. Do not take a double dose to make up for missed doses.
If you stop taking Claritromicina Accord
Do not stop taking your medicine because you feel better. It is important to take the tablets for the duration your doctor has prescribed, otherwise the problem may come back and this medicine may be less effective next time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking Claritromicina Accord and contact your doctor immediately if you experience any of the following symptoms during treatment:
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Side effects of unknown frequency(cannot be estimated from the available data):
Reporting of side effects:
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions. Keep in the original packaging to protect from moisture.
Do not use this medicine after the expiry date which is stated on the carton or blister after EXP. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Clarithromycin Accord
Tablet Core:Microcrystalline cellulose (E460), Sodium croscarmellose, Povidone K30, Talc (E553b), Colloidal anhydrous silica, Magnesium stearate (E470b), Stearic acid 50.
Coating:Yellow Opadry contains: Hypromellose 2910 (5mPa.s) (E464), Propylene glycol (E1520), Titanium dioxide (E171), Vanillin, Hydroxypropylcellulose (E463), Talc (E553b), Quinoline yellow (E104)
Product Appearance and Container Content
Clarithromycin Accord 500 mg film-coated tablets EFG: light yellow, oval, biconvex tablets marked with a "C" on one side and "2" on the other side of the tablet. The tablets have a length of 18.60 mm and a width of 8.85 mm.
Clarithromycin Accord 500 mg film-coated tablets EFG are packaged in blisters of 7, 10, 14, 16, 20, 21, 28, 30, 250 or 500 tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Accord Healthcare S.L.U.
World Trade Center
Moll de Barcelona, s/n
Edifici Est, 6th floor
08039 Barcelona
Manufacturer
Accord Healthcare B.V.,
Winthontlaan 200,
3526 KV Utrecht,
Netherlands
Laboratori Fundació Dau
C/ C, 12-14 Pol. Ind. Zona Franca,
Barcelona, 08040,
Spain
Accord Healthcare Polska Sp.z o.o.,
ul. Lutomierska 50,95
95-200 Pabianice,
Poland
Accord Healthcare Single Member S.A.
64th Km National Road Athens,
Lamia, 32009,
Greece
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Germany Clarithromycin Accord 500 mg Filmtabletten
Austria Clarithromycin Accord 500 mg Filmtabletten
Denmark Clarithromycin Accord
Spain Clarithromycin Accord 500 mg film-coated tablets
Finland Clarithromycin Accord 500 mg tablets, film-coated
France Clarithromycin Accord 500 mg film-coated tablets
Ireland Clarithromycin 500 mg film-coated tablets
Italy Clarithromycin Accord
Norway Clarithromycin Accord
Netherlands Clarithromycin Accord 500 mg film-coated tablets
Poland Klabiotic
Date of the last revision of this leaflet:March 2024
Detailed information on this medicinal product is available on the website of the {Spanish Agency for Medicines and Health Products (AEMPS)} (http://www.aemps.gob.es/)